Updated Warfarin Label Notes Genetics’ Impact On Dosing, But Avoids Recommending Test
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA adds pharmacogenetic information to warfarin label, says more specific recommendations on genetic testing and appropriate dosing await further studies.